Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China flag China · Delayed Price · Currency is CNY
8.50
-0.14 (-1.62%)
Feb 3, 2026, 3:00 PM CST

SHA:603567 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
203.821,0531,4541,0011,5511,539
Short-Term Investments
5.715.3914.7459.4513.63-
Trading Asset Securities
0.460.540.430.51--
Cash & Short-Term Investments
209.991,0691,4691,0611,5651,539
Cash Growth
-78.27%-27.22%38.43%-32.17%1.68%-39.74%
Accounts Receivable
3,1233,1562,5253,0413,3692,654
Other Receivables
1,0081,0851,955811.14796.85125.62
Receivables
4,1324,2424,4803,8524,1662,779
Inventory
1,5211,488720.891,006733.26959.54
Prepaid Expenses
--19.7267.5856.750.05
Other Current Assets
397.23394.08478.08394.31155.07722.92
Total Current Assets
6,2607,1937,1686,3816,6766,001
Property, Plant & Equipment
1,4031,4811,4261,4681,4551,460
Long-Term Investments
1,3131,2981,2661,2231,236859.65
Goodwill
14.8214.8214.8217.2218.518.5
Other Intangible Assets
1,031980.37784.03764.29209.36205.05
Long-Term Deferred Tax Assets
440.33321.12302.6242.28159.23149.9
Long-Term Deferred Charges
244.76246.06223.03217.62167.0588.21
Other Long-Term Assets
1,0901,1781,2821,3641,5851,452
Total Assets
11,79712,71312,46611,67811,50610,234
Accounts Payable
314.78278.16332.99806.25797581.33
Accrued Expenses
36.5150.8843.9235.7634.99100.77
Short-Term Debt
1,4631,296876.191,302600.76500
Current Portion of Long-Term Debt
1,218439.61972.691,1421,047574
Current Portion of Leases
-4.553.812.463.23-
Current Income Taxes Payable
95.68114.16101.9190.1356.8467.06
Current Unearned Revenue
153.7755.336.4654.9712.9841.04
Other Current Liabilities
275.43281.61387.2323.34259.28387.97
Total Current Liabilities
3,5572,5202,7553,8672,8122,252
Long-Term Debt
6071,5461,2984601,2902,134
Long-Term Leases
7.447.970.149.963.53-
Long-Term Unearned Revenue
141.04150.11169.34181.88197.24197.08
Long-Term Deferred Tax Liabilities
37.5937.9126.025.911.37-
Other Long-Term Liabilities
159.3159.3176.5746.37150.42147.92
Total Liabilities
4,5094,4224,4254,5714,4554,731
Common Stock
941941.14941.96941.96941.96849.16
Additional Paid-In Capital
2,3382,3392,3442,3502,3501,225
Retained Earnings
4,0164,5314,2813,8343,7493,417
Treasury Stock
-13.89-15.1-22.04-29.99--
Comprehensive Income & Other
7.194.993.933.22.753.62
Total Common Equity
7,2887,8017,5487,0997,0435,494
Minority Interest
-0.89490.45492.277.948.278.69
Shareholders' Equity
7,2878,2918,0417,1077,0515,503
Total Liabilities & Equity
11,79712,71312,46611,67811,50610,234
Total Debt
3,2953,2943,1512,9262,9453,208
Net Cash (Debt)
-3,085-2,225-1,682-1,865-1,380-1,669
Net Cash Per Share
-3.28-2.37-1.79-1.98-1.60-1.97
Filing Date Shares Outstanding
940.38941.09939.4939.4941.96849.16
Total Common Shares Outstanding
940.38941.09939.4939.4941.96849.16
Working Capital
2,7034,6734,4132,5153,8643,749
Book Value Per Share
7.758.298.047.567.486.47
Tangible Book Value
6,2436,8056,7506,3176,8155,271
Tangible Book Value Per Share
6.647.237.186.727.236.21
Buildings
-1,4041,2281,2321,2761,272
Machinery
-1,2701,1911,1391,1181,176
Construction In Progress
-149.42284.29260.83137.3366.14
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.